KIMBERLY BECK: Open Payments
NPI 1194203562 · GARNER, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,404 in 85 payments from 23 companies in 2025. Trend: 2023 $1,264 · 2024 $1,640 · 2025 $1,404
Food & beverage: $1,404
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 22 | $232 |
| PFIZER INC. | 15 | $203 |
| AstraZeneca Pharmaceuticals LP | 7 | $159 |
| Lilly USA, LLC | 8 | $134 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $77 |
| SHIELD THERAPEUTICS INC | 3 | $61 |
| ABBVIE INC. | 3 | $57 |
| Amgen Inc. | 3 | $55 |
| Abbott Laboratories | 2 | $42 |
| GlaxoSmithKline, LLC. | 2 | $41 |
Products named: NURTEC ODT, MOUNJARO, ELIQUIS, FARXIGA, Rybelsus, BREZTRI, ACCRUFER, XIFAXAN.
Industry payments across NC — which companies pay providers there.
